Effectivnes of edaravone on ischemic stroke
Phase 3
- Conditions
- Ischemic stroke.Cerebral infarction
- Registration Number
- IRCT20240224061102N1
- Lead Sponsor
- Yasouj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Participants with ischemic stroke based on clinical symptoms and CT scan
Participants with ischemic stroke and NIHSS score of 16
Exclusion Criteria
Unwillingness to participate
Significant cognitive and neurological impairments
Presence of hemorrhagic stroke
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ischemic Severity. Timepoint: First and 10 days after intervention. Method of measurement: CT scan.;Radiological improvement rate. Timepoint: First and 10 days after intervention. Method of measurement: CT scan.;Rate of clinical improvement. Timepoint: First and 10 days after intervention. Method of measurement: NIHSS Scoring.;The level of consciousness of the patient. Timepoint: First and 10 days after intervention. Method of measurement: GCS scoring system.
- Secondary Outcome Measures
Name Time Method